Australian University Rankings Guide

Contrast Media and Molecular Imaging (ERA Journal)

Contrast Media and Molecular Imaging is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Contrast Media and Molecular Imaging issns are issn1: 1555-4309 issn2: 1555-4317.

The fields covered by Contrast Media and Molecular Imaging as part of the evaluation of Australian university research excellence are:

Medicinal and Biomolecular Chemistry Research Rankings (Sub-Field)

Biomedical Engineering Research Rankings (Sub-Field)

Medical Biotechnology Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Medicinal and Biomolecular Chemistry field include:

- ACS Synthetic Biology
- Archiv der Pharmazie
- Bioconjugate Chemistry
- Biological and Pharmaceutical Bulletin
- Evolutionary Applications: evolutionary approaches to environmental biomedical and socio-economic issues
- FEBS Letters
- International Journal of Bioscience Biochemistry and Bioinformatics (IJBBB)
- Journal of Enzyme Inhibition and Medicinal Chemistry
- Medicinal Chemistry
- Molecular Informatics
- Molecular Medicine Reports
- Molecular and Cellular Probes
- Peptides
- Synlett: accounts and rapid communications in synthetic organic chemistry
- eJIFCC - electronic Journal of the International Federation of Clinical Chemistry and Laboratory Medicine


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4